Reaction
Hyperferritinaemia reporting signals
As of the last recalculation, Hyperferritinaemia appears in 409 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is ANAKINRA (PRR 135.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anakinra | 40 | 135.9 | 136.2 |
| Canakinumab | 19 | 93.7 | 93.8 |
| Dolutegravir Sodium | 14 | 81.7 | 81.9 |
| Lopinavir And Ritonavir | 15 | 58.4 | 58.5 |
| Thiotepa | 9 | 49.0 | 49.1 |
| Piperacillin And Tazobactam | 11 | 44.9 | 45.0 |
| Busulfan | 11 | 36.5 | 36.6 |
| Meropenem | 19 | 31.6 | 31.6 |
| Ceftriaxone | 19 | 30.9 | 30.9 |
| Tofacitinib Citrate | 7 | 27.6 | 27.6 |
| Fludarabine Phosphate | 20 | 27.2 | 27.2 |
| Eltrombopag Olamine | 9 | 20.3 | 20.3 |
| Blinatumomab | 4 | 19.7 | 19.7 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 15 | 17.3 | 17.3 |